New Risk • Apr 18
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 69% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 36% per year over the past 5 years. Shareholders have been substantially diluted in the past year (69% increase in shares outstanding). Minor Risk Market cap is less than US$100m (NT$1.73b market cap, or US$55.0m). 공지 • Apr 16
SunVic Technology Co., Ltd., Annual General Meeting, Jun 29, 2026 SunVic Technology Co., Ltd., Annual General Meeting, Jun 29, 2026, at 09:00 Taipei Standard Time. Location: 3 floor no,5, kung yeh 2nd rd., hsing nan ts`un, minsyong township, chiayi county Taiwan Buy Or Sell Opportunity • Apr 10
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 17% to NT$27.00. The fair value is estimated to be NT$34.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 20% over the last 3 years. Earnings per share has grown by 3.5%. Reported Earnings • Apr 02
Full year 2025 earnings released: NT$1.16 loss per share (vs NT$1.37 loss in FY 2024) Full year 2025 results: NT$1.16 loss per share (improved from NT$1.37 loss in FY 2024). Revenue: NT$340.7m (down 9.7% from FY 2024). Net loss: NT$43.7m (loss narrowed 11% from FY 2024). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 43% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Nov 15
Third quarter 2025 earnings released: NT$0.14 loss per share (vs NT$0.34 loss in 3Q 2024) Third quarter 2025 results: NT$0.14 loss per share (improved from NT$0.34 loss in 3Q 2024). Revenue: NT$87.4m (down 11% from 3Q 2024). Net loss: NT$5.01m (loss narrowed 59% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 37% per year but the company’s share price has increased by 49% per year, which means it is well ahead of earnings. Reported Earnings • Aug 15
Second quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.45 loss in 2Q 2024) Second quarter 2025 results: NT$0.42 loss per share (improved from NT$0.45 loss in 2Q 2024). Revenue: NT$73.8m (down 18% from 2Q 2024). Net loss: NT$15.3m (loss narrowed 5.3% from 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 65 percentage points per year, which is a significant difference in performance. New Risk • Aug 11
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: NT$297.0m (US$9.93m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$54m free cash flow). Share price has been highly volatile over the past 3 months (8.1% average weekly change). Earnings have declined by 21% per year over the past 5 years. Market cap is less than US$10m (NT$297.0m market cap, or US$9.93m). Reported Earnings • May 17
First quarter 2025 earnings released: NT$0.46 loss per share (vs NT$0.10 loss in 1Q 2024) First quarter 2025 results: NT$0.46 loss per share (further deteriorated from NT$0.10 loss in 1Q 2024). Revenue: NT$94.5m (up 8.3% from 1Q 2024). Net loss: NT$16.5m (loss widened 346% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. New Risk • May 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$51m free cash flow). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 18% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$319.3m market cap, or US$10.5m). Reported Earnings • Apr 02
Full year 2024 earnings released: NT$1.37 loss per share (vs NT$3.35 loss in FY 2023) Full year 2024 results: NT$1.37 loss per share (improved from NT$3.35 loss in FY 2023). Revenue: NT$377.4m (down 17% from FY 2023). Net loss: NT$49.3m (loss narrowed 59% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. 공지 • Mar 27
SunVic Technology Co., Ltd., Annual General Meeting, Jun 20, 2025 SunVic Technology Co., Ltd., Annual General Meeting, Jun 20, 2025. Location: 3 floor no,5, kung yeh 2nd rd., hsing nan ts`un, minsyong township, chiayi county Taiwan New Risk • Nov 29
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.2% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$14m free cash flow). Share price has been highly volatile over the past 3 months (8.2% average weekly change). Earnings have declined by 14% per year over the past 5 years. Market cap is less than US$10m (NT$301.3m market cap, or US$9.26m). New Risk • Nov 19
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: NT$306.7m (US$9.45m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$14m free cash flow). Earnings have declined by 14% per year over the past 5 years. Market cap is less than US$10m (NT$306.7m market cap, or US$9.45m). Minor Risk Share price has been volatile over the past 3 months (7.4% average weekly change). Reported Earnings • Nov 19
Third quarter 2024 earnings released: NT$0.34 loss per share (vs NT$0.005 profit in 3Q 2023) Third quarter 2024 results: NT$0.34 loss per share (down from NT$0.005 profit in 3Q 2023). Revenue: NT$97.8m (up 27% from 3Q 2023). Net loss: NT$12.1m (down NT$12.3m from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 18
Second quarter 2024 earnings released: NT$0.45 loss per share (vs NT$0.23 loss in 2Q 2023) Second quarter 2024 results: NT$0.45 loss per share (further deteriorated from NT$0.23 loss in 2Q 2023). Revenue: NT$89.8m (down 43% from 2Q 2023). Net loss: NT$16.2m (loss widened 91% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 109 percentage points per year, which is a significant difference in performance. New Risk • Jun 08
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.6% average weekly change). Market cap is less than US$10m (NT$182.0m market cap, or US$5.61m). Reported Earnings • May 19
First quarter 2024 earnings released: NT$0.10 loss per share (vs NT$0.43 loss in 1Q 2023) First quarter 2024 results: NT$0.10 loss per share (improved from NT$0.43 loss in 1Q 2023). Revenue: NT$87.2m (down 40% from 1Q 2023). Net loss: NT$3.69m (loss narrowed 76% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance. New Risk • Apr 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (NT$194.2m market cap, or US$6.07m). Minor Risk Share price has been volatile over the past 3 months (6.2% average weekly change). 공지 • Apr 04
SunVic Technology Co., Ltd., Annual General Meeting, Jun 21, 2024 SunVic Technology Co., Ltd., Annual General Meeting, Jun 21, 2024. Reported Earnings • Apr 03
Full year 2023 earnings released: NT$3.35 loss per share (vs NT$1.56 loss in FY 2022) Full year 2023 results: NT$3.35 loss per share (further deteriorated from NT$1.56 loss in FY 2022). Revenue: NT$456.1m (down 11% from FY 2022). Net loss: NT$120.6m (loss widened 114% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Reported Earnings • Aug 18
Second quarter 2023 earnings released: NT$0.24 loss per share (vs NT$0.40 loss in 2Q 2022) Second quarter 2023 results: NT$0.24 loss per share (improved from NT$0.40 loss in 2Q 2022). Revenue: NT$156.9m (up 60% from 2Q 2022). Net loss: NT$8.48m (loss narrowed 42% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth. New Risk • Aug 17
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: NT$306.3m (US$9.57m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$141m free cash flow). Market cap is less than US$10m (NT$306.3m market cap, or US$9.57m). Valuation Update With 7 Day Price Move • Dec 12
Investor sentiment improved over the past week After last week's 18% share price gain to NT$9.63, the stock trades at a trailing P/E ratio of 2.5x. Average trailing P/E is 14x in the Chemicals industry in Taiwan. Total returns to shareholders of 61% over the past three years. Reported Earnings • Nov 20
Third quarter 2022 earnings released: NT$0.47 loss per share (vs NT$0.47 loss in 3Q 2021) Third quarter 2022 results: NT$0.47 loss per share (further deteriorated from NT$0.47 loss in 3Q 2021). Revenue: NT$137.5m (up 70% from 3Q 2021). Net loss: NT$16.8m (flat on 3Q 2021). Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 23
Investor sentiment improved over the past week After last week's 21% share price gain to NT$11.60, the stock trades at a trailing P/E ratio of 3x. Average trailing P/E is 15x in the Chemicals industry in Taiwan. Total loss to shareholders of 5.7% over the past three years. Reported Earnings • Aug 19
Second quarter 2022 earnings released: NT$0.40 loss per share (vs NT$0.40 loss in 2Q 2021) Second quarter 2022 results: NT$0.40 loss per share (down from NT$0.40 loss in 2Q 2021). Revenue: NT$98.1m (down 9.4% from 2Q 2021). Net loss: NT$14.5m (loss widened 1.2% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 103% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Reported Earnings • May 20
First quarter 2022 earnings released: NT$0.37 loss per share (vs NT$0.024 profit in 1Q 2021) First quarter 2022 results: NT$0.37 loss per share (down from NT$0.024 profit in 1Q 2021). Revenue: NT$80.0m (down 24% from 1Q 2021). Net loss: NT$13.3m (down NT$14.1m from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 92% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Buying Opportunity • May 04
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 31%. The fair value is estimated to be NT$11.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 2.9% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment deteriorated over the past week After last week's 21% share price decline to NT$10.25, the stock trades at a trailing P/E ratio of 2.4x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total returns to shareholders of 48% over the past three years. Reported Earnings • Apr 04
Full year 2021 earnings released: EPS: NT$4.22 (vs NT$1.14 loss in FY 2020) Full year 2021 results: EPS: NT$4.22 (up from NT$1.14 loss in FY 2020). Revenue: NT$383.3m (down 5.6% from FY 2020). Net income: NT$152.1m (up NT$193.1m from FY 2020). Profit margin: 40% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 32% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 17
Third quarter 2021 earnings released: NT$0.47 loss per share (vs NT$0.031 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: NT$80.7m (down 22% from 3Q 2020). Net loss: NT$16.7m (down NT$17.9m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 19
Second quarter 2021 earnings released: NT$0.39 loss per share (vs NT$0.55 loss in 2Q 2020) The company reported a solid second quarter result with reduced losses, improved revenues and improved control over expenses. Second quarter 2021 results: Revenue: NT$108.2m (up 24% from 2Q 2020). Net loss: NT$14.4m (loss narrowed 28% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • May 20
First quarter 2021 earnings released: EPS NT$0.02 (vs NT$0.64 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$105.1m (up 14% from 1Q 2020). Net income: NT$880.0k (up NT$23.9m from 1Q 2020). Profit margin: 0.8% (up from net loss in 1Q 2020). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Reported Earnings • Apr 01
Full year 2020 earnings released: NT$1.14 loss per share (vs NT$1.18 loss in FY 2019) The company reported a mediocre full year result with weaker revenues, although its control over expenses remained stable and losses reduced. Full year 2020 results: Revenue: NT$406.0m (down 2.3% from FY 2019). Net loss: NT$40.9m (loss narrowed 3.6% from FY 2019). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Dec 16
New 90-day high: NT$5.80 The company is up 17% from its price of NT$4.97 on 17 September 2020. The Taiwanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period. Is New 90 Day High Low • Nov 26
New 90-day high: NT$5.12 The company is up 10.0% from its price of NT$4.67 on 27 August 2020. The Taiwanese market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 10.0% over the same period. Reported Earnings • Nov 18
Third quarter 2020 earnings released: EPS NT$0.03 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: NT$102.9m (down 9.7% from 3Q 2019). Net income: NT$1.11m (up NT$14.0m from 3Q 2019). Profit margin: 1.1% (up from net loss in 3Q 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Oct 24
New 90-day low: NT$4.25 The company is down 12% from its price of NT$4.81 on 24 July 2020. The Taiwanese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 2.0% over the same period.